Treatment of Depression After Coronary Bypass Surgery

Registration Number
NCT00042198
Lead Sponsor
Washington University School of Medicine
Brief Summary

This randomized controlled trial will test the efficacy of (1) cognitive behavior therapy and (2) supportive stress management as treatments for depression in people who have recently undergone coronary artery bypass graft surgery.

Detailed Description

Depression is a very common problem for people who have had CABG surgery, and recent studies have shown that it may increase the risk of additional medical problems and death during the first few years after surgery. Cognitive behavior therapy (CBT) has been shown to be efficacious for depression in otherwise healthy individuals, and supportive stress manage...

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
123
Inclusion Criteria
  • Coronary Artery Bypass Graft (CABG) surgery (alone or combined with valvular or carotid surgery) within past 12 months
  • Meets DSM-IV criteria for major or minor depressive episode
Read More
Exclusion Criteria
  • Severe cognitive impairment
  • Severe psychiatric comorbidity (e.g., alcoholism or schizophrenia)
  • Severely debilitating or life-threatening illness other than coronary disease
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Cognitive behavior therapyCognitive Behavior Therapy. The treatment modality was individual, face-to-face therapy with an experienced cognitive therapist. Treatment consisted of up to 12 weekly, hour-long sessions.
2Supportive Stress ManagementSupportive Stress Management. The treatment modality was individual, face-to-face therapy with an experienced psychotherapist. Treatment consisted of up to 12 weekly, hour-long sessions.
Primary Outcome Measures
NameTimeMethod
Hamilton Rating Scale for Depression (HAM-D-17)12 weeks post-randomization

The HAM-D-17 is an observer-rated measure of the severity of depression.

Secondary Outcome Measures
NameTimeMethod
Beck Depression Inventory12 weeks post-randomization

The BDI is a self-report measure of the severity of depression.

Beck Anxiety Inventory12 weeks post-randomization

The BAI is a self-report measure of the severity of anxiety symptoms.

Beck Hopelessness Scale12 weeks post-randomization

The BHS is a self-report measure of hopelessness.

Perceived Stress Scale12 weeks post-randomization

The PSS is a self-report measure of perceived stress

SF-3612 weeks post-randomization

The Medical Outcomes Study SF-36 is a measure of health-related quality of life. The Physical and Mental factor scores will be reported.

Trial Locations

Locations (1)

Washington University School of Medicine

🇺🇸

St. Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath